Cibinqo Tablet, Film Coated
Product Images NDC 63539-436

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cibinqo (NDC 63539-436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cibinqo 01)

FDA Label Image

Logo (Cibinqo 02)

Logo (Cibinqo 02)
The text is a label which includes the brand name "Pfizer" and information about distribution by Pfizer Labs, a division of Pfizer Inc. located in New York, NY 10017.*
FDA Label Image

Logo (Cibinqo 03)

Logo (Cibinqo 03)
This is a label of a Pfizer product. The label indicates that Pfizer Labs is responsible for the distribution of the product, which is a division of Pfizer Inc. The product might be sold in New York, NY, with the zip code of 10017.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
This text is a pharmaceutical product description for Abrocitinib tablets, containing 50mg per tablet. It includes temperature instructions for storage and warns against crushing, spitting, or chewing the tablets. The specific dosage and usage information can be found in the accompanying prescribing information. It is distributed by Pfizer Inc. and is Rx only.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
This is a description of the storage conditions and dosage instructions for Cibinqo tablets which contain 100mg of Rocitinib. The tablets should be stored between 20°C to 25°C (68°F to 77°F) and can be stored between 5°C to 30°C (59°F to 86°F). The tablets should not be crushed, split, or chewed. The text also mentions that further information about the medication can be found in the accompanying prescribing information. The tablets are distributed by U.S. Pharmaceuticals and the product is for professional sample use only and not for sale.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
This text is a prescription information about a medication called CIBINQO, which comes in a tablet form containing 200mg of abrocitinib. It should be stored at a temperature of 20°C to 25°C, with permitted excursions between 5°C to 30°C. Patients should always dispense the medication with a medication guide and not crush, split, or chew the tablets. The text also includes a product code, PCR-780-14906, and the manufacturer's name, Pfizer.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.